Showing results (31-40 of 420) with videos related to
Sort By:
Pageof 42
American Journal of Therapeutics|May 21, 2003
Viral respiratory infections due to rhinoviruses: current knowledge, new developmentsA Mark FendrickHealth Affairs (Project Hope)|January 23, 2010
Evidence that value-based insurance can be effectiveMichael E Chernew, Iver A Juster, Mayur Shah, et al.Implementation Science : IS|April 9, 2009
A controlled trial of value-based insurance design - the MHealthy: Focus on Diabetes (FOD) trialAlicen Spaulding, A Mark Fendrick, William H Herman, et al.Health Affairs (Project Hope)|January 9, 2008
Impact of decreasing copayments on medication adherence within a disease management environmentMichael E Chernew, Mayur R Shah, Arnold Wegh, et al.Journal of Managed Care & Specialty Pharmacy|August 29, 2019
Letter--Assessing the Effectiveness of V-BID ImplementationsBeth Shrosbree, A Mark FendrickThe American Journal of Managed Care|May 15, 2003
Effect of off-label use of oncology drugs on pharmaceutical costs: the rituximab experienceDarren Kocs, A Mark FendrickThe American Journal of Managed Care|May 22, 2020
Expanding coverage for essential care during COVID-19A Mark Fendrick, Beth ShrosbreeThe American Journal of Managed Care|July 19, 2018
Insights on site-of-care cancer research: both quality and cost information are necessary to guide policyKavita Patel, A Mark FendrickThe American Journal of Managed Care|December 21, 2017
Expanding the "safe harbor" in high-deductible health plans: better coverage and lower healthcare costsA Mark Fendrick, Rashna SoonavalaThe American Journal of Managed Care|November 14, 2022
Opportunity after crisis: enhancing value in the COVID-19 reboundDouglas Barthold, A Mark FendrickPageof 42